Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × PTC596 × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Cyclophosphamide 823 Radiotherapy 750 Cisplatin 644 Gemcitabine 570 Carboplatin 531 Docetaxel 526 Paclitaxel 519 Bevacizumab 498 Fluorouracil 447 Rituximab 400 Oxaliplatin 395 Capecitabine 395 Surveys and Questionnaires 380 Dexamethasone 379 Doxorubicin 370 Etoposide 360 Irinotecan 343 Cytarabine 326 Filgrastim 325 pembrolizumab 273 Leucovorin 271 Melphalan 262 fludarabine phosphate 253 Magnetic Resonance Spectroscopy 253 Nivolumab 247 Blood Specimen Collection 242 Lenalidomide 238 Peripheral Blood Stem Cell Transplantation 236 Bortezomib 234 Cetuximab 233

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03206645 2024-04-23

PTC-001

University of Oklahoma

Phase 1 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡